Article info
Acute coronary syndromes, chronic ischaemic heart disease
Education in Heart
Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting
- Correspondence to Deepak L Bhatt, Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA; dbhattmd{at}post.harvard.edu
Citation
Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting
Publication history
- First published November 25, 2016.
Online issue publication
January 18, 2021
Article Versions
- Previous version (8 July 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/